Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs).

Valiltramiprosate is a brain-penetrant small molecule that blocks amyloid from aggregating into toxic oligomers, which are ...

How do everyday health issues affect new blood tests for Alzheimer's disease? A study from Karolinska Institutet, published in Alzheimer's & Dementia, suggests that factors like kidney function, ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Experts explain why the shortfall is so common—and the simple diet or supplement changes that can help close the gap.

For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit ...

As Alzheimer’s Awareness Month comes to an end, Florida State University researchers are continuing efforts to better ...

Anavex Life Sciences' Phase 2B/3 trial failed to achieve statistical significance on both primary endpoints. Read why I ...

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...

LATE dementia, a progressive brain disorder affecting older adults, is increasingly being recognized as distinct from ...